The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really does help curb drinking ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

Novo’s blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ingredient as its popular obesity treatment Wegovy. The USFDA’s ...

To compile our list of the 12 best blue chip stocks to buy under $100, we used blue chip ETFs plus ... including Ozempic and Wegovy, have experienced significant sales growth due to their proven ...

“We don’t have the budgets of Allstate. We don’t have the budgets of Geico,” says Dan Kenger, chief design officer of Hims & Hers, during an interview. “If you can’t fight the ...